The J&J vaccine is the third authorised in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses. The US Food and Drug Administration announced the emergency use authorisation of the J&J vaccine for adults aged 18 and older following Friday’s unanimous endorsement by the agency’s panel of outside experts.… Read More: US authorises J&J’s COVID-19 vaccine, making it third available »
WASHINGTON — COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist they will be able to provide enough for most Americans to get inoculated by summer. By the end of March, Pfizer and Moderna expect to have provided the… Read More: Drug executives: Big jump in vaccine supply is coming soon »
“Those who are vaccine hesitant have had their hesitancy enhanced by a variety of things that are happening right now, particularly the unfortunate mix of science and politics,” Collins said at an event hosted by the National Academies of Sciences, Engineering and Medicine. A recent poll from the Kaiser Family Foundation found that more than… Read More: Most Americans probably won’t be able to get a Covid-19… »
Prime Minister Scott Morrison announced on Friday it has terminated its $ 1 billion deal for the vaccine candidate being developed by the University of Queensland (UQ) and global biotech company CSL because trial participants were returning false-positive HIV test results. There were fears these results could undermine confidence in other vaccine candidates, so the… Read More: ‘Unexpected finding’ killed vaccine trial »